View printer-friendly version << Back
MEDNAX Acquires Dallas Neonatal Group Practice

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 2, 2009-- MEDNAX, Inc., (NYSE:MD) has completed the acquisition of Associates in Neonatology, P.A., a physician group practice based in Dallas, Texas, that will practice as part of Pediatrix Medical Group, the national group practice of neonatal, maternal fetal, pediatric cardiology and other pediatric subspecialists that is an operating division of MEDNAX.

The practice includes four physicians who staff the Level III neonatal intensive care unit (NICU) at Methodist Dallas Medical Center, where annual patient volume includes more than 15,000 NICU patient days and more than 3,000 well baby nursery patient days. The group will be integrated into Pediatrix’s existing neonatal group practice of more than 850 neonatologists who are constantly contributing to the nation’s largest neonatal outcomes database through Pediatrix’s electronic health record system.

“We have been looking for ways to improve the quality of our care, and we believe that being among a community of physicians, working together, there’s an opportunity to share information on treatments to get better outcomes for our patients,” said Harold Kolni, M.D., who will serve as Pediatrix’s medical director at Methodist Dallas. “With the movement toward electronic health records, we think the ability to collect data, and to share best practices, will lead to better outcomes and more cost-effective care.”

Pediatrix’s clinical data warehouse is used to drive clinical research, continuing medical education and clinical quality initiatives that seek ways to improve care for premature and ill newborns.

During 2009, Pediatrix’s national group practice has expanded to include the addition of four neonatal physician groups, one maternal-fetal medicine group and a pediatric cardiology practice.

The Associates in Neonatology practice was acquired for cash, and the transaction is expected to be immediately accretive to MEDNAX’s earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc., is a national medical group that comprises the nation’s leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation’s largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,275 physicians in 32 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

MEDNAX, Inc., Fort Lauderdale
Bob Kneeley, Director, Investor Relations, 954-384-0175, x 5300